Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

317 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Saccharomyces boulardii in childhood.
Vandenplas Y, Brunser O, Szajewska H. Vandenplas Y, et al. Eur J Pediatr. 2009 Mar;168(3):253-65. doi: 10.1007/s00431-008-0879-7. Epub 2008 Dec 19. Eur J Pediatr. 2009. PMID: 19096876 Review.
Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants.
Szajewska H, Kotowska M, Mrukowicz JZ, Armańska M, Mikołajczyk W. Szajewska H, et al. J Pediatr. 2001 Mar;138(3):361-5. doi: 10.1067/mpd.2001.111321. J Pediatr. 2001. PMID: 11241043 Clinical Trial.
RESULTS: LGG reduced the risk of nosocomial diarrhea (> or =3 loose or watery stools/24 h) in comparison with placebo (6.7% vs 33.3%; relative risk: 0.2; [95% CI: 0.06-0.6]; number needed to treat: 4 [95% CI: 2-10]). ...
RESULTS: LGG reduced the risk of nosocomial diarrhea (> or =3 loose or watery stools/24 h) in comparison with placebo (6.7% vs 33. …
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.
Kotowska M, Albrecht P, Szajewska H. Kotowska M, et al. Aliment Pharmacol Ther. 2005 Mar 1;21(5):583-90. doi: 10.1111/j.1365-2036.2005.02356.x. Aliment Pharmacol Ther. 2005. PMID: 15740542 Clinical Trial.
RESULTS: Patients receiving S. boulardii had a lower prevalence of diarrhoea (> or =3 loose or watery stools/day for > or =48 h occurring during or up to 2 weeks after the antibiotic therapy) than those receiving placebo [nine of 119 (8%) vs. 29 of 127 (23%), relativ …
RESULTS: Patients receiving S. boulardii had a lower prevalence of diarrhoea (> or =3 loose or watery stools/day for > or =48 h
Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial.
Banaszkiewicz A, Szajewska H. Banaszkiewicz A, et al. J Pediatr. 2005 Mar;146(3):364-9. doi: 10.1016/j.jpeds.2004.10.022. J Pediatr. 2005. PMID: 15756221 Clinical Trial.
Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children.
Szajewska H, Skórka A, Dylag M. Szajewska H, et al. Aliment Pharmacol Ther. 2007 Feb 1;25(3):257-64. doi: 10.1111/j.1365-2036.2006.03202.x. Aliment Pharmacol Ther. 2007. PMID: 17269987
Probiotics and prebiotics in pediatrics: where are we now?
Szajewska H. Szajewska H. Turk J Pediatr. 2007 Jul-Sep;49(3):231-44. Turk J Pediatr. 2007. PMID: 17990574 Review.
Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children.
Ruszczyński M, Radzikowski A, Szajewska H. Ruszczyński M, et al. Aliment Pharmacol Ther. 2008 Jul;28(1):154-61. doi: 10.1111/j.1365-2036.2008.03714.x. Epub 2008 Apr 13. Aliment Pharmacol Ther. 2008. PMID: 18410562 Clinical Trial.
RESULTS: Any diarrhoea (>or=3 loose or watery stools/day for >or=48 h occurring during or up to 2 weeks after the antibiotic therapy) occurred in nine (7.5%) patients in the probiotic group and in 20 (17%) patients in the placebo group (relative risk, RR 0.45, 95% co …
RESULTS: Any diarrhoea (>or=3 loose or watery stools/day for >or=48 h occurring during or up to 2 weeks after the antibiotic th …
Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial.
Szymański H, Armańska M, Kowalska-Duplaga K, Szajewska H. Szymański H, et al. Digestion. 2008;78(1):13-7. doi: 10.1159/000151300. Epub 2008 Aug 14. Digestion. 2008. PMID: 18701826 Clinical Trial.
RESULTS: Patients receiving probiotics had a similar rate of diarrhea (> or =3 loose or watery stools/day for > or =48 h occurring during or up to 2 weeks after the antibiotic therapy) as those receiving placebo (relative risk 0.5, 95% CI 0.06-3.5). ...
RESULTS: Patients receiving probiotics had a similar rate of diarrhea (> or =3 loose or watery stools/day for > or =48 h occurr …
317 results
Jump to page
Feedback